Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Zomedica Pharmaceuticals stock
Learn how to easily invest in Zomedica Pharmaceuticals stock.
Zomedica Pharmaceuticals Corp is a drug manufacturers-specialty & generic business based in the US. Zomedica Pharmaceuticals shares (ZOM) are listed on the NYSE MKT and all prices are listed in US Dollars. Zomedica Pharmaceuticals employs 47 staff and has a trailing 12-month revenue of around $12.1 million.
How to buy shares in Zomedica Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ZOM – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Zomedica Pharmaceuticals stock price (NYSE MKT: ZOM)Use our graph to track the performance of ZOM stocks over time.
Zomedica Pharmaceuticals shares at a glance
|Latest market close||$0.21|
|52-week range||$0.18 - $0.60|
|50-day moving average||$0.27|
|200-day moving average||$0.29|
|Wall St. target price||$1.20|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.02|
Buy Zomedica Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Zomedica Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Zomedica Pharmaceuticals price performance over time
|1 week (2022-09-27)||-0.90%|
|1 month (2022-09-02)||-7.77%|
|3 months (2022-07-01)||1.06%|
|6 months (2022-04-04)||-38.18%|
|1 year (2021-10-04)||-60.41%|
|2 years (2020-10-02)||118.75%|
|3 years (2019-10-04)||0.3151|
|5 years (2017-10-04)||2.25|
Zomedica Pharmaceuticals financials
|Revenue TTM||$12.1 million|
|Gross profit TTM||$3.1 million|
|Return on assets TTM||-5.03%|
|Return on equity TTM||-6.95%|
|Market capitalisation||$206.8 million|
TTM: trailing 12 months
Zomedica Pharmaceuticals share dividends
We're not expecting Zomedica Pharmaceuticals to pay a dividend over the next 12 months.
Zomedica Pharmaceuticals share price volatility
Over the last 12 months, Zomedica Pharmaceuticals's shares have ranged in value from as little as $0.175 up to $0.6. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Zomedica Pharmaceuticals's is 0.6624. This would suggest that Zomedica Pharmaceuticals's shares are less volatile than average (for this exchange).
Zomedica Pharmaceuticals overview
Zomedica Corp. , a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and markets a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp.
Zomedica Pharmaceuticals in the news
Zomedica To Present at Dawson James Securities 7th Annual Small Cap Growth Conference
Zomedica Announces Launch of Free T4 Assay for Truforma(R) Diagnostic Platform
Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference
Frequently asked questionsWhat percentage of Zomedica Pharmaceuticals is owned by insiders or institutions?
Currently 1.483% of Zomedica Pharmaceuticals shares are held by insiders and 9.916% by institutions. How many people work for Zomedica Pharmaceuticals?
Latest data suggests 47 work at Zomedica Pharmaceuticals. When does the fiscal year end for Zomedica Pharmaceuticals?
Zomedica Pharmaceuticals's fiscal year ends in December. Where is Zomedica Pharmaceuticals based?
Zomedica Pharmaceuticals's address is: 100 Phoenix Drive, Ann Arbor, MI, United States, 48108 What is Zomedica Pharmaceuticals's ISIN number?
Zomedica Pharmaceuticals's international securities identification number is: CA98980M1095 What is Zomedica Pharmaceuticals's CUSIP number?
Zomedica Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 98979F107
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert